https://www.selleckchem.com/pr....oducts/1-deoxynojiri
BACKGROUND Due to its eloquent location and potentially devastating neurological consequences, the management of brainstem cavernous malformations (CCMs) attracts considerable debate. There is currently a paucity of Level 1 evidence for their management. The aim of this literature review is to explore the current evidence on the risk-benefit profile of different management options. METHODS A systemic literature search, following the PRISMA algorithm was performed on publications between 2010 and 2018 using the Pubmed database
Like
Comment
Share
